Biofourmis-Novartis Partnership to Launch Project in Southeast Asia

The project’s initial phase started this month and is expected to roll out across Southeast Asia.

Biofourmis-Novartis Partnership to Launch Project in Southeast Asia | BEAMSTART News

- From our Sponsors -

Singapore’s health tech startup Biofourmis announced a collaboration with global healthcare company Novartis to form a commercial project for managing patients with heart failure.

The program aims to improve clinical outcomes by using Biofourmis’ flagship product, BiovitalsHF, which captures data from wearable sensors.

- Featured Sponsor -

Before expanding globally, the program is set to start in five countries in Southeast Asia, including Singapore.

Founded in 2015 in Singapore, Biofourmis closed a US$35 million series B funding round in May and moved its headquarters from Singapore to Boston.

“The ultimate goal of this alliance is to work with Novartis to drive better patient-centric outcomes and arm providers across the globe with the right actionable information early enough to better manage their patients with heart failure,” said Biofourmis founder and CEO Kuldeep Singh Rajput.

- From our Sponsors -

BEAMSTART is a Hub for Startup News, Business Networking, and Entrepreneurial Resources. Expand your network, discover new possibilities, and tap into a vast database of resources that can help you go further in your business and career.


Download the App

The app for business networking and startup resources. Be part of the global community of CEOs, Business Leaders, and Professionals. Download below to instantly form partnerships and discover opportunities:

PlayStore ButtonAppStore Button

© 2016 - 2021 BEAMSTART. All Rights Reserved (Legal).